Neuro-Immune Aspects of Schizophrenia with Severe Negative Symptoms: New Diagnostic Markers of Disease Phenotype.

Sovrem Tekhnologii Med · 2021 · PMC8858398 · PMID 35265356

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the majority of patients with severe negative symptoms, the serum neurotrophin NGF level was several-fold higher than that in the control group and that in patients with NSA-4 scores <15 ( Figure (e) ); however, the differences between the groups did not reach statistical significance due to large data variations.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.